Market Tracker

01/16 1:05pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.33
Delayed Data
As of Jan 13
 -0.30 / -1.92%
Today’s Change
13.00
Today|||52-Week Range
101.40
+5.58%
Year-to-Date

Today’s Trading

Previous close15.63
Today’s open15.70
Day’s range15.28 - 15.79
Volume11,117,733
Average volume (3 months)17,556,920
Market cap$5.2B
Dividend yield--
Data as of 4:01pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-131.25%
Earnings growth (this year)-46.51%
Earnings growth (next 5 years)+9.40%
Revenue growth (last year)+26.42%
P/E ratioNM
Price/Sales3.32
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc-0.04-0.44%
MNKMallinckrodt Plc-0.98-1.90%
IONSIonis Pharmaceutical...-1.45-2.93%
GRFSGrifols SA+0.25+1.50%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.22
Annual revenue (last year)$10.4B
Annual profit (last year)-$291.7M
Net profit margin-2.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts